Unlock this StockReport nowClick to Unlock

BTG Share Price

BTG 834.5p 1.0  0.1%
4:35pm 3.00k
StockRank

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Mar 2013 2014 2015 2016 2017 2018 TTM 2019E 2020E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Dividends
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $ +10.5%

FINANCIAL BRIEF: For the six months ended 30 September 2018, BTG plc revenues increased 12% to $495.7M. Net income increased 13% to $77.4M. Revenues reflect Product segment increase of 10% to $340.2M, Licensing segment increase of 18% to $155.5M, USA segment increase of 12% to $452.7M, Europe segment increase of 12% to $31.6M, Other Region segment increase of 25% to $11.4M. Net income benefited from Unallocated segment loss decrease of 32% to $71.2M. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
D+
D+
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 30th Sep '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Mar 2019
31st Mar 2020

Price Target: 7.63
(-8.41% below Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
9 brokers Broker Consensus Trend
Broker Recommendations for BTG
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 1 6 2 0

Named Brokers and Analysts
Deutsche Bank Richard Parkes , Stifel Nicolaus and Company, Incorporated Max Herrmann , Jefferies Peter Welford , RBC Capital Markets Zoe Karamanoli , Investec Bank (UK) Plc Andrew Whitney , Panmure Gordon Julie Simmonds , Numis Securities Paul Cuddon , Peel Hunt Amy Walker , Mirabaud Securities David Hallam , JPMorgan James Gordon , Shore Capital Stockbrokers Adam Barker , Cantor Fitzgerald Europe Brian White ,

Profile Summary

BTG plc is medical device development and healthcare service provider. It provides Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care and licensing business. It operates through three segments: Interventional Medicine, Pharmaceuticals and Licensing. The Interventional Medicine segment includes oncology, vascular and pulmonology. The segment's products include Beads, TheraSphere, EkoSonic, Varithena and PneumRx Coils for use in the treatment of liver tumors, blood clots, varicose veins and advanced emphysema. The Pharmaceuticals segment includes CroFab, DigiFab, Voraxaze and Vistogard products for use in the treatment of crotalid envenomation, digoxin toxicity, high-dose methotrexate toxicity and 5-fluorouracil toxicity. The Licensing segment includes Zytiga, Two-Part Hip Cup and Lemtrada products for use in the treatment of advanced prostate cancer, hip replacement and multiple sclerosis.

Directors: Dame Pamela Louise Makin (CEO) , Duncan Kennedy (CFO) , Paul Mussenden (GCN) , Gregory Barrett (NID) 64, Susan Foden (NID) , Graham Hetherington (NID) 56, Ian Much (NID) , W. James O'Shea (NID) 67,

No. of Employees: 1,512 No. of Shareholders: 8,147


Last Annual March 31st, 2018
Last Interim September 30th, 2018
Incorporated December 12, 1991
Public Since June 28, 1995
Shares in Issue 387,225,871
Free Float 377.6m (97.5%)

BTG Share Price Performance BTG Share Price Quote
834.5p
1.0  0.1%
Traded 4:35pm · Minimum 15 min delayed · NMS: 3.00k

Latest BTG News Announcements (delayed)

Upcoming BTG Events
Thursday 28th February, 2019
BTG PLC Court Meeting
Thursday 28th February, 2019
BTG PLC Ordinary Shareholders Meeting
Monday 13th May, 2019 (estimate)
Full Year 2019 BTG PLC Earnings Release

Recent ↓
Tuesday 13th November, 2018
Half Year 2019 BTG PLC Earnings Call
Tuesday 13th November, 2018
Half Year 2019 BTG PLC Earnings Release
Thursday 4th October, 2018
BTG PLC Close Period Update
Wednesday 18th July, 2018
BTG PLC Annual Shareholders Meeting
Tuesday 15th May, 2018
Full Year 2018 BTG PLC Earnings Presentation
Tuesday 15th May, 2018
Full Year 2018 BTG PLC Earnings Release
Wednesday 9th May, 2018
BTG PLC at Deutsche Bank Health Care Conference
Tuesday 24th April, 2018
BTG PLC at Berenberg UK Corporate Conference
Monday 2nd April, 2018 (estimate)
BTG PLC Pre-Close Statement Release
Thursday 5th April, 2018
BTG PLC Trading Statement Release
Thursday 11th January, 2018
BTG PLC at JPMorgan Healthcare Conference
Thursday 7th December, 2017
BTG PLC Interventional Medicine Seminar
Tuesday 14th November, 2017
Half Year 2018 BTG PLC Earnings Presentation
Tuesday 14th November, 2017
Half Year 2018 BTG PLC Earnings Release
Thursday 5th October, 2017
BTG PLC Close Period Update
Thursday 13th July, 2017
BTG PLC Annual Shareholders Meeting
Tuesday 16th May, 2017
Full Year 2017 BTG PLC Earnings Call
Tuesday 16th May, 2017
Full Year 2017 BTG PLC Earnings Release
Thursday 4th May, 2017
BTG PLC at Deutsche Bank Health Care Conference
Thursday 6th April, 2017
BTG PLC Close Period Update


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.


Should you buy BTG

Access BTG Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis